One bright spot for AGN in 1Q13: Botox. 1Q13 Botox sales were $458M, +15% YoY in local currencies (but -4% QoQ vs record $475 amount in 4Q12 due to seasonality). The YoY increase was helped by new indications and price increases.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”